GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » SpectraCure AB (OSTO:SPEC) » Definitions » ROE % Adjusted to Book Value

SpectraCure AB (OSTO:SPEC) ROE % Adjusted to Book Value : -8.74% (As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is SpectraCure AB ROE % Adjusted to Book Value?

SpectraCure AB's ROE % for the quarter that ended in Mar. 2024 was -18.87%. SpectraCure AB's PB Ratio for the quarter that ended in Mar. 2024 was 2.16. SpectraCure AB's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 was -8.74%.

SpectraCure AB ROE % Adjusted to Book Value Historical Data

The historical data trend for SpectraCure AB's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SpectraCure AB ROE % Adjusted to Book Value Chart

SpectraCure AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.68 -1.31 -3.85 -4.81 -5.05

SpectraCure AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.35 -3.94 -5.28 -4.58 -8.74

Competitive Comparison of SpectraCure AB's ROE % Adjusted to Book Value

For the Medical Devices subindustry, SpectraCure AB's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

SpectraCure AB's ROE % Adjusted to Book Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, SpectraCure AB's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where SpectraCure AB's ROE % Adjusted to Book Value falls into.


SpectraCure AB ROE % Adjusted to Book Value Calculation

SpectraCure AB's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-14.59% / 2.89
=-5.05%

SpectraCure AB's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-18.87% / 2.16
=-8.74%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SpectraCure AB ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of SpectraCure AB's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

SpectraCure AB (OSTO:SPEC) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » SpectraCure AB (OSTO:SPEC) » Definitions » ROE % Adjusted to Book Value
Comparable Companies
OSTO:OSSD OSTO:BOUL OSTO:PAX OSTO:STIL OSTO:PRO OSTO:INTEG B OSTO:EPIS B OSTO:IRRAS OSTO:CLS B OSTO:NOSA ABT SYK MDT BSX SZSE:300760 EW DXCM ZBH STE XAMS:PHIA
Traded in Other Exchanges
N/A
Address
Magistratsvagen 10, Lund, SWE, 22643
Website
http://www.spectracure.com
SpectraCure AB develops treatment planning and laser light dose management for cancer treatment. The Company has developed its software IDOSE, and medical laser devices for the treatment.